U.S. markets closed

TSX Venture Exchange Stock Maintenance Bulletins

VANCOUVER , March 10, 2020 /CNW/ -

TSX VENTURE COMPANIES

EFFICACIOUS ELK CAPITAL CORP. ("EECC.P")
BULLETIN TYPE:  Resume Trading
BULLETIN DATE:  March 10, 2020
TSX Venture Tier 2 Company

Effective at the opening on Thursday, March 12, 2020 , trading in the common shares of the Company will resume, an announcement having been made. On March 10, 2020 , the Company announced the expiration of the letter of intent entered into with Frontier Wellness Management Inc. and the termination of the proposed Qualifying Transaction between the parties.

For further information, please refer to the Company's press releases dated July 23, 2019 , September 12, 2019 , November 18, 2019 and March 10, 2020 , which are available under the Company's profile on SEDAR.

________________________________________

HANSCO CAPITAL CORP. ("HCO.P")
BULLETIN TYPE:  New Listing-CPC-Shares, HALT
BULLETIN DATE:  March 10, 2020
TSX Venture Tier 2 Company

This Capital Pool Company's (the Company) Prospectus dated December 20, 2019 has been filed with and accepted by TSX Venture Exchange and the British Columbia and Alberta Securities Commissions effective December 24, 2019 pursuant to the provisions of the British Columbia Securities Act and Multilateral Instrument 11-102 Passport System in Alberta.  The Common Shares of the Company will be listed on TSX Venture Exchange on the effective date stated below.

The Company intends to complete its initial distribution of securities to the public.  The gross proceeds to be received by the Company for the Offering will be $300,000 (3,000,000 common shares at $0 .10 per share).

Commence Date:                                   

At the market open March 12, 2020 the Common shares will be
listed and immediately halted
 on TSX Venture Exchange.

 

The closing of the public offering is scheduled to occur on March 12 , 2020.  A further notice will be issued upon receipt of closing confirmation and the trading halt will be lifted.

Corporate Jurisdiction:                           

British Columbia



Capitalization:                                       

unlimited common shares with no par value of which
6,000,000  common shares will be issued and outstanding at the
closing of the offering



Escrowed Shares:                                

3,000,000  common shares will be subject to escrow at the closing of the offering



Transfer Agent:                                                  

Computershare Investor Services Inc.

Trading Symbol:                                                 

HCO.P

CUSIP Number:                                                  

41130L100

Agent:                                                               

Leede Jones Gable Inc.



Agent's Warrants:                                   

300,000 non-transferable warrants.  One warrant entitles the holder to purchase one common share of the Company at $0.10 per share for a period of 24 months from listing date.

 

For further information, please refer to the Company's Prospectus dated December 20, 2019 .

Company Contact:                               

Aris Morfopoulos

Company Address:                              

600-890 West Pender St. Vancouver, BC V6C 1K4

Company Phone Number:                     

604-721-2650

Company Fax Number:                         

604-357-1030

Company Email Address:                    

aris@morfopoulos.com

 

________________________________________

20/03/10  - TSX Venture Exchange Bulletins

TSX VENTURE COMPANIES

ADVANCED PROTEOME THERAPEUTICS CORPORATION. ("APC")
BULLETIN TYPE:  Shares for Bonuses
BULLETIN DATE:  March 10, 2020
TSX Venture Tier 2 Company

TSX Venture Exchange has accepted for filing the Company's proposal to issue 289,372  bonus shares to three lenders  in consideration of loans totaling $72,343.10 .  The loans bear interest at 15% per annum and mature January 27, 2021

________________________________________

BIONEUTRA GLOBAL CORPORATION ("BGA")
BULLETIN TYPE:  Property-Asset or Share Purchase Agreement
BULLETIN DATE:  March 10, 2020
TSX Venture Tier 1 Company

TSX Venture Exchange has accepted for filing documentation a proposed share purchase agreement (the Agreement") dated September 24, 2019 , between the Company and Canada Asia Synergy Group Corp.

Under the Agreement, the Company will purchase all of the issued and outstanding shares of BioNeutra HK Limited, a wholly owned subsidiary of Canada Asia Synergy Group Corp. incorporated under the laws of Hong Kong . In return, the Company will provide USD$30,000 in cash payments and 200,000 common share purchase warrants ("Warrants") as total consideration for this transaction. Each Warrant is exercisable at $0.40 for a period of 5 years to acquire one common share of the Company. 

This transaction is considered a Non-Arm's Length transaction because of Mr. Doug Horner is involved as a director of both, Canada Asia Synergy Group Corp. and the Company.

For further details, please see the Company's news releases dated December 5, 2019 and March 6, 2020 .

________________________________________

CONVERGE TECHNOLOGY SOLUTIONS CORP. ("CTS")
BULLETIN TYPE:  Prospectus-Share Offering
BULLETIN DATE:  March 10, 2020
TSX Venture Tier 2 Company

The Company's Short Form Base Shelf Prospectus dated July 8, 2019 was filed with and receipted by the Ontario Securities Commission, pursuant to the provisions of the Securities Act ( Ontario ), on July 12, 2019 . The Prospectus was also filed under Multilateral Instrument 11-102 Passport System in British Columbia , Alberta , Saskatchewan , Manitoba , Quebec , New Brunswick , Nova Scotia , Prince Edward Island and Newfoundland and Labrador.  A receipt for the Prospectus is deemed to be issued by the regulator in each of those jurisdictions, if the conditions of the Instrument have been satisfied.

TSX Venture Exchange has accepted for filing documentation with respect to a bought deal offering of 5,769,231 common shares (not including common shares issuable under the Greenshoe Option, referenced below) of the Company at a price of $1.30 per share for total gross proceeds of $7,500,000.30 (the "Offering"). The Offering was made pursuant to a Prospectus Supplement dated February 13, 2020 to the Company's Short Form Base Shelf Prospectus dated July 8, 2019 .

TSX Venture Exchange has been advised that closing of the Offering occurred on February 20, 2020 , for gross proceeds of $7,500,000.30 . TSX Venture Exchange has been further advised that the underwriters partially exercised their Greenshoe Option to purchase an additional 592,084 common shares of the Company at a price of $1.30 per share for additional gross proceeds of $769,709.20 , which closed on March 3, 2020 . The total gross proceeds of the Offering and partial exercise of the Greenshoe Option were $8,269,709.50 .

Agents:                                    

Raymond James Ltd., as lead underwriter, Paradigm Capital Inc. and Hampton Securities Limited



Offering:                                  

5,769,231 common shares



Share Price:                            

$1.30 per share



Agents' Warrants:                     

None



Greenshoe Option:                   

The Agents may over-allot the shares in connection with the Offering and the Company has granted to the Agents an option to purchase additional shares, up to 15% of the Offering, at $1.30 for gross proceeds of $1,124,999.20, up to 12:00 p.m. (Toronto time) on March 21, 2020. The Agents have purchased 592,084 shares pursuant to the Greenshoe Option for gross proceeds of $769,709.20.

 

For further information, please refer to the Company's Short Form Base Shelf Prospectus dated July 8, 2019 , Prospectus Supplement dated February 13, 2020 , and news releases dated February 11, 2020 , February 12, 2020 , February 20, 2020 and March 3, 2020 .

________________________________________

INCA ONE GOLD CORP. ("IO")
BULLETIN TYPE:  Warrant Price Amendment
BULLETIN DATE:  March 10, 2020
TSX Venture Tier 2 Company

TSX Venture Exchange has consented to the reduction in the exercise price of the following warrants:

Private Placement:




# of Warrants:                                                    

4,140,000

Expiry Date of Warrants:                                    

January 31, 2021

Forced Exercise Provision:                               

If the closing price for the Company's shares is $0.50 or
greater for a period of 10 consecutive trading days, then the
warrant holders will have 30 days to exercise their warrants;
otherwise the warrants will expire on the 31st day.

Original Exercise Price of Warrants:                    

$0.75 year 1 (one), $1.00 years 2 (two) and 3 (three)

New Exercise Price of Warrants:                       

$0.40

 

These warrants were issued pursuant to a private placement of 4,600,000 shares with 4,600,000 share purchase warrants attached, which was accepted for filing by the Exchange effective February 14, 2018 .

________________________________________

INCA ONE GOLD CORP. ("IO")
BULLETIN TYPE:  Shares for Debt
BULLETIN DATE:  March 10, 2020
TSX Venture Tier 2 Company

TSX Venture Exchange has accepted for filing the Company's proposal to issue 528,986 shares at a deemed price of $0.20 to settle outstanding debt for $105,797 .

Number of Creditors:                

4 Creditors

 

Insider / Pro Group Participation:










Creditor                                  

Insider=Y / 
Progroup=P
 

Amount
Owing

Deemed Price
per Share

# of Shares

Ed Kelly                                      

Y

$48,191

$0.20

240,957

Kevin Hart                                   

Y

$42,606

$0.20

213,029

Bruce Bragagnolo                       

Y

$10,000

$0.20

50,000

Rodney Stevens                         

Y

$5,000

$0.20

25,000

 

The Company shall issue a news release when the shares are issued and the debt extinguished.

________________________________________

KALYTERA THERAPEUTICS INC. ("KLY") ("KLY.WT.B") ("KLY.WT.A")
BULLETIN TYPE:  Resume Trading
BULLETIN DATE:  March 10, 2020
TSX Venture Tier  1 Company

Effective at  6:30 a.m. PST, March 10, 2020 , shares of the Company resumed trading, an announcement having been made.

________________________________________

MEDEXUS PHARMACEUTICALS INC. ("MDP")
BULLETIN TYPE:  Property-Asset or Share Purchase Agreement
BULLETIN DATE: March 10, 2020
TSX Venture Tier 2 Company

TSX Venture Exchange has accepted for filing documentation in relation to a purchase agreement (the Agreement") dated February 28, 2020 between the Company and Aptevo Therapeutics Inc. (the "Vendor"). Pursuant to the Agreement, the Company will acquire all of the outstanding limited liability interests of the Vendor for upfront cash consideration of approximately US$30 million . The acquisition will be financed entirely with existing cash and a new US$20 million term loan credit facility with MidCap Financial.

For further information, please refer to the Company's press release dated February 28, 2020 .

________________________________________

PROVIDENCE GOLD MINES INC. ("PHD")
BULLETIN TYPE:  Private Placement-Non-Brokered
BULLETIN DATE:  March 10, 2020
TSX Venture Tier 2 Company

TSX Venture Exchange has accepted for filing documentation with respect to a Non-Brokered Private Placement announced Jan 28, 2020 :

Number of Shares:                   

850,000 shares



Purchase Price:                        

$0.10 per share



Warrants:                                 

850,000 share purchase warrants to purchase 850,000 shares



Warrant Initial Exercise Price:    

$0.15



Warrant Term to Expiry:            

1 Year



Number of Placees:                  

3 Placees

 

Insider / Pro Group Participation:



Name

Insider=Y /
Pro-Group=P

# of Shares

Rodger  Young

Y

250,000

Ronald  Coombes  

Y

100,000

 

Note that in certain circumstances the Exchange may later extend the expiry date of the warrants, if they are less than the maximum permitted term.

The above information is a summary only.  Neither TMX Group Limited nor any of its affiliated companies guarantee the accuracy or completeness of the information contained in this document.  Readers should consult the issuer's continuous disclosure record for complete details of the transaction.

________________________________________

SILVER SPRUCE RESOURCES INC. ("SSE")
BULLETIN TYPE:  Private Placement-Non-Brokered
BULLETIN DATE:  March 10, 2020
TSX Venture Tier 2 Company

TSX Venture Exchange has accepted for filing documentation with respect to a Non-Brokered Private Placement announced December 16, 2019 :

Number of Shares:                   

4,890,000 non flow-through units ("Non FT Unit") and 300,000 flow-through
units ("FT Unit"). Each Non FT Unit consists of one common share and one
common share purchase warrant. Each FT Unit consists of one flow-through
common share and one common share purchase warrant.



Purchase Price:                       

$0.05 per Non FT Unit and $0.05 per FT Unit



Warrants:                               

4,890,000 non flow-through warrants ("Non FT Warrant") and 300,000 flow-
through warrants ("FT Warrant")



Warrant Exercise Price:            

$0.075 for a two-year period for Non FT Warrants and $0.075 for a one-year
period for FT Warrants



Number of Placees:                  

4 placees

 

Insider / Pro Group Participation:






Name

Insider=Y /
ProGroup=P

# of Units




Cedar Forest Inc.



(Kevin O'Connor)

Y

250,000 Non FT

Gregory Davidson

Y

140,000 Non FT

Brian Penney

Y

200,000 FT

 

Finder's Fee: 

$7,500 cash and 300,000 common shares at a deemed price of $0.05 per
share payable to Albert Timcke.

 

Pursuant to Corporate Finance Policy 4.1, Section 1.9(e), the Company issued a news release on March 4, 2020 announcing the closing of the private placement and setting out the expiry dates of the hold period(s).

________________________________________

SOURCE TSX Venture Exchange


Cision

View original content: http://www.newswire.ca/en/releases/archive/March2020/10/c4413.html